Collegium Pharmaceutical, Inc

Ownership Transactions Reported by 17 Insiders

Symbol
COLL on Nasdaq
Location
100 Technology Center Drive, Stoughton, MA

Insiders trading volume in the past year

Collegium Pharmaceutical, Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Joseph Ciaffoni President and CEO, Director $15M Feb 12, 2024
Colleen Tupper EVP & Chief Financial Officer $5.47M -$674K -11% Feb 10, 2025
Shirley R. Kuhlmann EVP and General Counsel $4.71M -$2.5M -34.7% Feb 10, 2025
Alison B. Fleming EVP & Chief Technical Officer $4.64M Aug 10, 2021
Scott Dreyer EVP & Chief Commercial Officer $4.51M -$4.03M -47.2% Feb 10, 2025
Richard Malamut EVP and Chief Medical Officer $4.2M Feb 10, 2022
Vikram Karnani President and CEO, Director $3.88M Nov 12, 2024
John G. Freund Director $3.1M May 16, 2024
Thomas B. Smith EVP and Chief Medical Officer $2.68M -$388K -12.7% Feb 10, 2025
Gino Santini Director $2.44M May 16, 2024
John A. Fallon Director $1.77M May 16, 2024
Garen Bohlin Director $1.69M -$936K -35.6% May 14, 2024
Gwen A. Melincoff Director $1.69M May 16, 2024
Neil F. McFarlane Director $1.59M May 16, 2024
Michael T. Heffernan Director $1.54M Feb 10, 2025
Rita J. Balice-Gordon Director $1.5M May 16, 2024
Nancy Lurker Director $428K Feb 4, 2025

Recent Insider Transactions by Companies or Individuals for Collegium Pharmaceutical, Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.